FOPAL
Live / Registered — Registered (as of 13 Oct 2026)
What this means for you
Registered since 13 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97623952
- Registration number
- 8497999
- Mark type
- Design + words
- Filed
- 07 Oct 2022
- Published for opposition
- 25 Aug 2026
- Registered
- 13 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 13 Oct 2032 (grace period to 13 Apr 2033)
- Attorney of record
- Makiko Coffland
Goods and services
- Class 035 — Advertising and business services: Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducting business and market research surveys in the fields of pharmaceuticals and clinical trials
- Class 042 — Scientific and technological services: Providing a website featuring medical and scientific research educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment
- Class 044 — Medical, beauty and agricultural services: Providing an online computer database featuring a compilation of medical information and patient records being medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients in the field of Fibrodysplasia ossificans progressiva (FOP) disease; health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information; conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes
Owner
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
Prosecution history
- 13 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jul 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 22 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 22 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 22 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 15 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 19 May 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED